Board of Directors

Board of Directors

Shlomo Ben-Haim

MD, D.Sc – Chairman of the Board
Dr. Ben-Haim is the co-founder of a number of successful medical and biomedical companies in the fields of congestive heart failure, obesity, diabetes, esthetics and cosmetics, anti-viral medications, deep vein thrombosis prevention, therapy for limb ischemia and post-stroke and sports-injury rehabilitation. His formal education is in the fields of nuclear physics, mathematics, biomedical engineering, philosophy and medicine. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics, at Harvard University and the Technion – Israel Institute of Technology. Dr. Ben-Haim has published over 100 scientific papers in peer-reviewed journals and holds over 180 patents and patent applications.

Dr. Simos Kedikoglou

MD, CFA, MBA – Director
Dr. Simos Kedikoglou is the President of the MedInvest group. He was previously a Corporate Vice President of Business Development for Boston Scientific with responsibility for acquisitions, licensing and distribution deals in the US, Europe and Asia. Prior to Boston Scientific, Simos was an Associate Partner with McKinsey & Company in the US, focusing on M&A and has advised clients in completed healthcare deals with a combined value of $45 billion. Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction and a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.

James Keyes

James Keyes is a Bermuda resident and citizen. He was a partner of Appleby, the offshore law firm, for eleven years, until he retired from the firm in 2008. He joined Appleby in 1993 and was team leader of the Funds & Investment Services Team. Prior to Appleby, he was employed in the Corporate Department of Freshfields law firm, and worked in the London, New York and Hong Kong offices.
James attended Oxford University in England as a Rhodes Scholar and graduated with a degree in Politics, Philosophy and Economics (M.A. with Honours) in 1985. He was admitted as a Solicitor in England & Wales in 1991 and to the Bermuda Bar in 1993.
James acts as a non-executive director of a number of funds and companies. He is also a managing director of Renaissance Capital, the emerging markets investment group. He became a Notary Public in 1998.
Your message was sent successfully